Exhibit 4.3
ELI LILLY AND COMPANY
Officers’ Certificate Pursuant to
Section 3.01 of the Indenture
, 2021
The undersigned, Philip Johnson, Senior Vice President, Finance, and Treasurer of Eli Lilly and Company, an Indiana corporation (the “Company”), and Jonathan Groff, Counsel—Corporate Securities and Assistant Secretary of the Company, pursuant to Section 3.01 of the Indenture dated as of February l, 1991 (the “Indenture”), between the Company and Deutsche Bank Trust Company Americas (as successor to Citibank, N.A.), as trustee (the “Trustee”), as authorized by resolutions of the Board of Directors of the Company, dated February 7, 2019 and August 10, 2021, and minutes of the Risk Management Committee of the Company at its meeting on July 27, 2021 (collectively, the “Board Resolutions”), do hereby certify as follows:
(i) There are hereby established four series of debt securities to be issued under the Indenture. The title of such series of the debt securities shall be the “0.500% Notes due 2033” (the “0.500% Notes”), “1.125% Notes due 2051” (the “1.125% Notes”), “1.375%% Notes due 2061” (the “1.375% Notes”) and the “1.625% Notes due 2043” (the “1.625% Notes” and, collectively with the 0.500% Notes, the 1.125% Notes and the 1.375% Notes, the “Notes”), respectively.
(ii) The four series of Notes shall be in the forms, and shall have the terms, set forth as Annex A-1, Annex A-2, Annex A-3 and Annex A-4, respectively, attached hereto. The Notes shall be issued in the form of Registered Securities and shall not be issued in the form of Bearer Securities.
(iii) The initial limit upon the aggregate principal amount of the Notes that may be authenticated and delivered under the Indenture (except for Notes authenticated and delivered upon registration or transfer of, or in exchange for, or in lieu of, other Notes pursuant to Section 3.04, 3.05, 3.06, 4.03 or 10.04 of the Indenture) is six hundred million euros (€600,000,000) with respect to the 0.500% Notes, five hundred million euros (€500,000,000) with respect to the 1.125% Notes, seven hundred million euros (€700,000,000) with respect to the 1.375% Notes and two hundred and fifty million pounds sterling (£250,000,000) with respect to the 1.625% Notes; provided, however, that, without the consent of the Holders of any Securities, the Company may at any time issue additional Securities having the same terms as the Notes of a particular series other than the date of original issuance and the first Interest Payment Date applicable to such additional Securities. Any such additional Securities will constitute a single series of Securities with the applicable Notes under the Indenture.
(iv) The principal amount of each Note shall be payable on September 14, 2033 with respect to the 0.500% Notes, September 14, 2051 with respect to the 1.125% Notes, September 14, 2061 with respect to the 1.375% Notes and September 14, 2043 with respect to the 1.625% Notes, unless redeemed prior to such time in accordance with clause (xiii) below.